Vertex Pharmaceuticals Inc (VRTX)
397.27
+0.63
(+0.16%)
USD |
NASDAQ |
Dec 20, 16:00
395.00
-2.27
(-0.57%)
After-Hours: 20:00
Vertex Pharmaceuticals Market Cap: 102.31B for Dec. 20, 2024
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Eli Lilly and Co | 728.85B |
| Gilead Sciences Inc | 115.37B |
| Bristol-Myers Squibb Co | 116.28B |
| Pfizer Inc | 149.38B |
| PTC Therapeutics Inc | 3.566B |
Market Cap Related Metrics
| PS Ratio | 9.73 |
| Price to Book Value | 6.545 |
| Price | 397.27 |
| Earnings Yield | -0.50% |
| Operating PE Ratio | 27.86 |
| Normalized PE Ratio | 39.25 |